Luxembourg vs Uganda: Access to anti-retroviral drugs, female
Luxembourg
87.0%
in 2024
Uganda
88.0%
in 2024
Luxembourg rank
45th
Uganda rank
44th
Access to anti-retroviral drugs, female over time
- Luxembourg
- Uganda
How they compare
Uganda currently reports 88.0% against 87.0% in Luxembourg, a difference of 1.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Luxembourg ahead.
Luxembourg ranks 45th and Uganda ranks 44th of 141 countries.
Across the 3 decades both report, Luxembourg averaged higher in 2 and Uganda in 1.
Head to head by decade
| Decade | Luxembourg | Uganda | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 43.3% | 6.3% | 37.0% | Luxembourg |
| 2010s | 64.1% | 52.4% | 11.7% | Luxembourg |
| 2020s | 80.2% | 83.4% | 3.2% | Uganda |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Luxembourg or Uganda?
- Uganda, at 88.0% against 87.0% in Luxembourg as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Luxembourg and Uganda?
- 1.0%, with Uganda ahead.
- How many years of comparable data are there for Luxembourg and Uganda?
- 25 years are reported by both, from 2000 to 2024.
- How do Luxembourg and Uganda rank globally for access to anti-retroviral drugs, female?
- Luxembourg ranks 45th and Uganda ranks 44th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.